Oncology PracticeSurvival, QoL better with nivolumab for recurrent head and neck cancerOctober 14, 2016Head & Neck/Thyroid Cancers
Oncology PracticeATA’s risk assessment guidelines for thyroid nodules using sonography patterns validatedOctober 3, 2016Head & Neck/Thyroid Cancers
The Journal of Community and Supportive OncologyDental oncology in patients treated with radiation for head and neck cancerSeptember 28, 2016Head & Neck/Thyroid CancersPatient & Survivor Care
Oncology PracticeLess pain, quicker discharge with post-TORS dexamethasoneSeptember 23, 2016Head & Neck/Thyroid Cancers
Oncology PracticeClearing tumor bed margins may not improve oral cancer outcomesAugust 18, 2016Head & Neck/Thyroid Cancers
Oncology PracticePost-TORS neck dissections extend hospital stayAugust 12, 2016Head & Neck/Thyroid Cancers
Oncology PracticePreop G-tubes save money in head and neck cancer resectionsAugust 9, 2016Head & Neck/Thyroid CancersPractice ManagementBusiness of Medicine
Oncology PracticeIntraoperative nerve stimulation reduces risk of shoulder pain from neck dissectionAugust 9, 2016Head & Neck/Thyroid Cancers
Oncology PracticeFDA grants accelerated approval to pembrolizumab for advanced HNSCCAugust 9, 2016Head & Neck/Thyroid Cancers
Oncology PracticeSkip SNL biopsy for desmoplastic melanomaAugust 8, 2016MelanomaHead & Neck/Thyroid Cancers
Oncology PracticeTestosterone might counteract chemotherapy heart damageAugust 2, 2016Head & Neck/Thyroid CancersGynecologic Cancer
Oncology PracticeFDA grants priority review to nivolumab for head and neck cancerJuly 20, 2016Head & Neck/Thyroid CancersGenitourinary Cancer
Oncology PracticeSU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaMultiple MyelomaImmuno-oncologyRenal Cell Carcinoma
Oncology PracticePembrolizumab paired with immunostimulator is safe and tolerableJune 15, 2016Genitourinary CancerHead & Neck/Thyroid CancersLung CancerImmuno-oncology
Oncology PracticeMyPathway: Targeted therapies show promise in nonindicated tumorsJune 8, 2016GastroenterologyLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersMelanomaRare Diseases
